Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
International Centre For Bamboo And Rattan has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is overseen by 1 distinct examiner and 1 distinct art unit. For a company with 1 pending office action, this concentration means that the entire current prosecution strategy is tied to the decisions of a single individual. Practitioners should prioritize understanding the specific requirements and historical tendencies of the assigned examiner to ensure a smooth path forward.
ROBINSON, KEITH O NEAL is the busiest examiner for this portfolio, currently overseeing 1 pending office action. Because ROBINSON, KEITH O NEAL is the only examiner involved, their feedback will be the primary factor in the success of the portfolio. The presence of 1 distinct art unit indicates that the Biotechnology & Pharmaceuticals technology being pursued is categorized within a specific technical group at the USPTO. This concentration allows the legal team to focus their efforts on the standards of 1 distinct art unit rather than navigating multiple sets of guidelines. Success will likely depend on a direct and effective dialogue with the assigned examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBINSON, KEITH O NEAL | 1 | 91.6% | +3.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19270528 | PHYLLOSTACHYS EDULIS-DERIVED PheXTH2 PROTEIN FOR REGULATING CULM CELL WALL THICKNESS OF PLANT, AND ENCODING GENE AND USE THEREOF | ROBINSON, KEITH O NEAL | — |
| Art Unit | Apps |
|---|---|
| 1661 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19270528 | PHYLLOSTACHYS EDULIS-DERIVED PheXTH2 PROTEIN FOR REGULATING CULM CELL WALL THICKNESS OF PLANT, AND ENCODING GENE AND USE THEREOF | ROBINSON, KEITH O NEAL | 1661 | §103§112 | Non-Final OA | — | Pending | Jul 16, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInternational Centre For Bamboo And Rattan has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Keith O Neal Robinson has the most, with 1 of International Centre For Bamboo And Rattan's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
